BASEL, Switzerland, Nov. 10 /PRNewswire/ - Neuro-Biotech Corporation (PINKSHEET: MRES) (OTCQB: MRES)
Neuro-Biotech Corp. is currently actively working towards the commercialization of natural products called "Neuroceuticals®", that are specially designed to restore the nervous system equilibrium and improve the state of health as well as the quality of life of people affected by stress-related disorders.
Our "Neuroceuticals®" respect international established quality standards (USP, EP and JP) in regards with purity, strength, and consistency of the products for human consumption.
According with our licences, we have a portfolio of four (4) innovative and selective products.
Those four (4) products will be sold and distributed by many means; directly from us under our own label as well as through "Private labels" such as pharmacies, megastore and natural products brands. Since we are actively in a negotiation process, it will be the distributor's mandate, in terms of their respective part of the market, to target the clientele they believe should be reached.
For more detailed information on the scientific data and the Neuroceuticals®, we invite you to consult our website at neuro-biotechcorp.com under the products section.
Neuro-Biotech is currently negotiating with 2 separates groups on the East coast and West coast for them to distribute the Neuroceuticals®. Management also decided that in order to maximize the market penetration and based on the product composition, it was it the Company's best interest to categorize the Neuroceuticals® as Natural Products and Food Supplements.
For more information, do not hesitate to contact us by using the contact form on our corporate website at neuro-biotechcorp.com. Your request will be transferred to the appropriate persons and we will get back to you as soon as possible.
|SOURCE Neuro-Biotech Corp.|
Copyright©2010 PR Newswire.
All rights reserved